Cyclic catalysis of intratumor Fe3+/2+ initiated by a hollow mesoporous iron sesquioxide nanoparticle for ferroptosis therapy of large tumors
Source abstract
Abstract
Numerous nanoparticles have been utilized to deliver Fe2+ for tumor ferroptosis therapy, which can be readily converted to Fe3+via Fenton reactions to generate hydroxyl radical (•OH). However, the ferroptosis therapeutic efficacy of large tumors is limited due to the slow conversion of Fe3+ to Fe2+via Fenton reactions. Herein, a strategy of intratumor Fe3+/2+ cyclic catalysis is proposed for ferroptosis therapy of large tumors, which was realized based on our newly developed hollow mesoporous iron sesquioxide nanoparticle (HMISN). Cisplatin (CDDP) and Gd-poly(acrylic acid) macrochelates (GP) were loaded into the hollow core of HMISN, whose surface was modified by laccase (LAC). Fe3+, CDDP, GP, and LAC can be gradually released from CDDP@GP@HMISN@LAC in the acidic tumor microenvironment. The intratumor O2 can be catalyzed into superoxide anion (O2•-) by LAC, and the intratumor NADPH oxidases can be activated by CDDP to generate O2•-. The O2•- can react with Fe3+ to generate Fe2+, and raise H2O2 level via the superoxide dismutase. The generated Fe2+ and H2O2 can be fast converted into Fe3+ and •OH via Fenton reactions. The cyclic catalysis of intratumor Fe3+/2+ initiated by CDDP@GP@HMISN@LAC can be used for ferroptosis therapy of large tumors.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis · Nanocluster Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. The cell biology of ferroptosis10.1038/s41580-024-00703-5 ↗
2. A guide to cell death pathways10.1038/s41580-023-00689-6 ↗
3. C. Wu, Z. Liu, Z. Chen, D. Xu, L. Chen, H. Lin, J. Shi, A nonferrous ferroptosis-like strategy for antioxidant inhibition–synergized nanocatalytic tumor therapeutics, Sci. Adv. 7(39) eabj8833.10.1126/sciadv.abj8833 ↗
4. An overview on mechanism, cause, prevention and multi-nation policy level interventions of dietary iron deficiency10.1080/10408398.2021.1879005 ↗
5. From the NIH: magnetic device tests for iron overload10.1001/jama.1985.03360080016003 ↗
6. Strategies for enhancing cancer chemodynamic therapy performance10.1002/EXP.20210238 ↗
7. Recent progress of metal-based nanomaterials with anti-tumor biological effects for enhanced cancer therapy10.1002/EXP.20220001 ↗
8. Structure–relaxivity mechanism of an ultrasmall ferrite nanoparticle T1 MR contrast agent: the impact of dopants controlled crystalline core and surface disordered shell10.1021/acs.nanolett.0c04574 ↗
9. An adenosine triphosphate-responsive autocatalytic fenton nanoparticle for tumor ablation with self-supplied H2O2 and acceleration of Fe(III)/Fe(II) conversion10.1021/acs.nanolett.8b03178 ↗
10. Small-sized gadolinium oxide based nanoparticles for high-efficiency theranostics of orthotopic glioblastoma10.1016/j.biomaterials.2020.119783 ↗
11. Tumor microenvironment-triggered MoS2@GA-Fe nanoreactor: a self-rolling enhanced chemodynamic therapy and hydrogen sulfide treatment for hepatocellular carcinoma10.1016/j.cej.2020.126888 ↗
12. A glucose/oxygen-exhausting nanoreactor for starvation- and hypoxia-activated sustainable and cascade chemo-chemodynamic therapy
13. Structural and molecular fusion MRI nanoprobe for differential diagnosis of malignant tumors and follow-up chemodynamic therapy10.1021/acsnano.2c12874 ↗
14. Blocking glutathione regeneration: inorganic NADPH oxidase nanozyme catalyst potentiates tumoral ferroptosis10.1016/j.nantod.2022.101574 ↗
15. A harmless–harmful switchable and uninterrupted laccase-instructed killer for activatable chemodynamic therapy10.1002/adma.202100114 ↗
16. An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers10.1038/s41467-022-29862-9 ↗
17. Good steel used in the blade: well-tailored type-I photosensitizers with aggregation-induced emission characteristics for precise nuclear targeting photodynamic therapy10.1002/advs.202100524 ↗
18. Triple-jump photodynamic theranostics: mno2 combined upconversion nanoplatforms involving a type-i photosensitizer with aggregation-induced emission characteristics for potent cancer treatment10.1002/adma.202103748 ↗
19. Bandgap-engineered germanene nanosheets as an efficient photodynamic agent for cancer therapy
20. A nanoscale trans-platinum(II)-Based supramolecular coordination self-assembly with a distinct anticancer mechanism10.1002/adma.202312488 ↗
21. Hydrazided hyaluronan/cisplatin/indocyanine green coordination nanoprodrug for photodynamic chemotherapy in liver cancer10.1016/j.carbpol.2021.118810 ↗
22. Laccase-based self-amplifying catalytic system enables efficient antibiotic degradation for sustainable environmental remediation10.1002/advs.202300210 ↗
23. Determination of reactive oxygen species generated in laccase catalyzed oxidation of wood fibers from Chinese fir (Cunninghamia lanceolata) by electron spin resonance spectrometry10.1016/j.biortech.2008.06.010 ↗
24. Laccase-mediated oxidation of small organics: bifunctional roles for versatile applications10.1016/j.tibtech.2013.04.002 ↗
25. Enhancing the production of hydroxyl radicals by pleurotus eryngii via quinone redox cycling for pollutant removal10.1128/AEM.02138-08 ↗
26. Aqueous and template-free synthesis of meso-macroporous polymers for highly selective capture and conversion of carbon dioxide10.1002/cssc.201701666 ↗
27. Drug delivery strategies for platinum-based chemotherapy10.1021/acsnano.7b04092 ↗
28. Controlled release of cisplatin from pH-thermal dual responsive nanogels10.1016/j.biomaterials.2013.07.092 ↗
29. Nanostructured Pt-doped tin oxide films: sol−gel preparation, spectroscopic and electrical characterization10.1021/cm001228o ↗
30. Metastable-phase platinum oxide for clarifying the Pt–O active site for the hydrogen evolution reaction10.1039/D2EE03351H ↗
31. High-resolution X-ray photoelectron spectroscopy of organometallic (C5H4SiMe3)3LnIII and [(C5H4SiMe3)3LnII]1– Complexes (Ln = Sm, Eu, Gd, Tb)10.1021/jacs.1c06980 ↗
32. Engineered bio-heterojunction confers extra- and intracellular bacterial ferroptosis and hunger-triggered cell protection for diabetic wound repair10.1002/adma.202305277 ↗
33. Laccase and its role in production of extracellular reactive oxygen species during wood decay by the brown rot basidiomycete Postia placenta10.1128/AEM.02929-09 ↗
34. A laccase with antiproliferative activity against tumor cells from an edible mushroom, white common Agrocybe cylindracea10.1016/j.phymed.2010.07.004 ↗
35. Microgel bioreactors for cancer cell targeting by pH-dependent generation of radicals10.1021/acs.molpharmaceut.9b00531 ↗
36. Nanoscintillator-mediated X-ray-triggered boosting transformation of Fe3+ into Fe2+ for Enhancing Tumor ferroptosis/immunotherapy10.1002/adfm.202301462 ↗
37. Comprehensively optimizing fenton reaction factors for antitumor chemodynamic therapy by charge-reversal theranostics10.1021/acsnano.3c03279 ↗
38. Amplification of lipid peroxidation by regulating cell membrane unsaturation to enhance chemodynamic therapy10.1002/anie.202218407 ↗
39. Facile synthesis of weakly ferromagnetic organogadolinium macrochelates-based T1-weighted magnetic resonance imaging contrast agents10.1002/advs.202205109 ↗
40. Reticular chemistry-enabled sonodynamic activity of covalent organic frameworks for nanodynamic cancer therapy10.1002/anie.202302146 ↗
41. Iron-siRNA nanohybrids for enhanced chemodynamic therapy via ferritin heavy chain downregulation10.1002/anie.202302255 ↗
42. Molecular bases of cellular iron toxicity12 1Guest Editor: mario Comporti 2This article is part of a series of reviews on “Iron and Cellular Redox Status.” the full list of papers may be found on the homepage of the journal10.1016/S0891-5849(02)00772-4 ↗
43. A lysosome-locating and acidic pH-activatable fluorescent probe for visualizing endogenous H2O2 in lysosomes10.1039/C7AN01280B ↗
44. Ferritinophagy mediated by oxidative stress-driven mitochondrial damage is involved in the polystyrene nanoparticles-induced ferroptosis of lung injury10.1021/acsnano.3c07255 ↗
45. Urchin-like ceria nanoparticles for enhanced gene therapy of osteoarthritis10.1126/sciadv.adf0988 ↗
46. Long noncoding RNA MAGI2-AS3 regulates the H2O2 level and cell senescence via HSPA810.1016/j.redox.2022.102383 ↗
47. Mitochondria and cancer10.1016/j.cell.2016.07.002 ↗
48. Hydroxyl radical is a significant player in oxidative DNA damage in vivo10.1039/D1CS00044F ↗
49. Biodegradable nanoscale coordination polymers for targeted tumor combination therapy with oxidative stress amplification10.1002/adfm.201908865 ↗
50. A “Closed-Loop” therapeutic strategy based on mutually reinforced ferroptosis and immunotherapy10.1002/adfm.202111784 ↗
51. Dual key co-activated nanoplatform for switchable MRI monitoring accurate ferroptosis-based synergistic therapy10.1016/j.chempr.2022.03.009 ↗
52. Targeted Manganese doped silica nano GSH-cleaner for treatment of Liver Cancer by destroying the intracellular redox homeostasis10.7150/thno.46771 ↗